Nasdaq May 2024 Volumes
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2024 on its...
Month: June 2024
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its...
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively...
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating...
Intel and Apollo Agree to Joint Venture Related to Intel’s Fab 34 in Ireland
Contacts Kylie Altman Intel Investor Relations 1-916-356-0320 kylie.altman@intel.com Sophie Won Intel Media Relations 1-408-653-0475 sophie.won@intel.com Noah Gunn Apollo, Global Head...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, June 04, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...
HeartSciences Regains Compliance with Nasdaq Listing Requirements
Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
HeartSciences Regains Compliance with Nasdaq Listing Requirements
Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market initiatives
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- HashiCorp, Inc. (NASDAQ: HCP), The Infrastructure Cloud™ company, today announced a strategic...
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
EMERYVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop...
Acquisition of Fusion Pharmaceuticals Completed
HAMILTON, ON and BOSTON, June 4, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation...
EZCORP to Participate in June Conferences
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) today announced its participation in the following conferences:The...
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja California Desalination Project
GEORGE TOWN, Cayman Islands, June 04, 2024 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a...
CrowdStrike Reports First Quarter Fiscal Year 2025 Financial Results
Ending ARR grows 33% year-over-year to reach $3.65 billion Net new ARR grows 22% year-over-year to $212 million Delivers record...
Cerence Names Tony Rodriquez as Interim Chief Financial Officer
BURLINGTON, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that...
Celldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a...
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warrant Adjustment
Louisville, Colorado, June 04, 2024 (GLOBE NEWSWIRE) -- CEA Industries Inc. (the “Company”) (NASDAQ: CEAD) announced that it approved a...
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warrant Adjustment
Louisville, Colorado, June 04, 2024 (GLOBE NEWSWIRE) -- CEA Industries Inc. (the “Company”) (NASDAQ: CEAD) announced that it approved a...
Azenta Announces Collaboration with the Crohn’s & Colitis Foundation to Support its Crohn’s Disease and Ulcerative Colitis Clinical Research
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel...
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts Astria Contact: Investor Relations and Media: Elizabeth Higgins investors@astriatx.com Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing...
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
COPENHAGEN, Denmark, June 04, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate...
Agilysys to Participate in Baird 2024 Global Consumer, Technology & Services Conference
Contacts Investor Contact: Jessica Hennessy, Agilysys, Inc., 770-810-6116, investorrelations@agilysys.com Agilysys, Inc., (Nasdaq: AGYS), a leading global provider of hospitality software...
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology...
HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
TORONTO, June 04, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), an AI...
Westport et Volvo Group annoncent la clôture de la joint venture
Travailler ensemble pour accélérer la commercialisation et l'adoption mondiale de la technologie de système de carburant HPDI™ de Westport pour les...
Verint Announces Strong Q1 FYE 2025 Results
Revenue and Diluted EPS Come in Ahead of Guidance World’s Leading Brands Select Verint Open Platform for Tangible AI Business...
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
MALVERN, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial-stage medical technology company...
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
WEST JORDAN, Utah, June 04, 2024 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. (“Sportsman's Warehouse” or the “Company”) (Nasdaq: SPWH)...
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHARLESTOWN, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision...
Stitch Fix Announces Third Quarter of Fiscal Year 2024 Financial Results
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Stitch Fix, Inc. (NASDAQ: SFIX), the trusted online personal styling service, today...
Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
Contacts Investor Relations & Media Contact: Robin Garner Vice President and Head of Investor Relations Repare Therapeutics Inc. investor@reparerx.com Repare...
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
COLUMBUS, Ohio, June 04, 2024 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and...
RGP Appoints Roger Carlile to Its Board of Directors
Contacts Media Contact: Pat Burek Financial Profiles (US+) 1-310-622-8244 pburek@finprofiles.com Investor Contact: Jenn Ryu, Chief Financial Officer (US+) 1-714-430-6500 jennifer.ryu@rgp.com...
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
NOVATO, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
Personalis will host a webinar call on June 19th, 2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time...
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
LEHI, Utah, June 4, 2024 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple") a comfort innovation company known for creating...
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s...
NetApp Hosts Investor Day
Contacts (Investors) Billie Fagenstrom NetApp 1 408 822 6428 billie.fagenstrom@netapp.com (Press) Kenya Hayes 1 703 589 7595 kenya.hayes@netapp.com NetApp, Inc....
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass. and DUBLIN, June 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing...